IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vorwerk, C. K.
Right arrow Articles by Dreyer, E. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vorwerk, C. K.
Right arrow Articles by Dreyer, E. B.

Investigative Ophthalmology & Visual Science, Vol 37, 1618-1624, Copyright © 1996 by Association for Research in Vision and Ophthalmology

ARTICLES AND REPORTS

Chronic low-dose glutamate is toxic to retinal ganglion cells. Toxicity blocked by memantine

CK Vorwerk, SA Lipton, D Zurakowski, BT Hyman, BA Sabel and EB Dreyer
Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, Boston, MA 02114, USA.

PURPOSE: It is well known that acute exposure to high concentrations of glutamate is toxic to central mammalian neurons. However, the effect of a chronic, minor elevation over endogenous glutamate levels has not been explored. The authors have suggested that such chronic exposure may play a role in glaucomatous neuronal loss. In the current study, they sought to explore whether a chronic, low-dose elevation in vitreal glutamate was toxic to retinal ganglion cells and whether this toxicity could be prevented with memantine, a glutamate antagonist. METHODS: Rats were injected serially and intravitreally with glutamate to induce chronic elevations in glutamate concentration. A second group of rats was treated with intraperitoneal memantine and glutamate. Control groups received vehicle injection with or without concurrent memantine therapy. After 3 months, the animals were killed, and ganglion cell survival was evaluated. RESULTS: Intravitreal injections raised the intravitreal glutamate levels from an endogenous range of 5 to 12 microM glutamate to 26 to 34 microM. This chronic glutamate elevation killed 42% of the retinal ganglion cells after 3 months. Memantine treatment alone had no effect on ganglion cell survival. However, when memantine was given concurrently with low-dose glutamate, memantine was partially protective against glutamate toxicity. CONCLUSIONS: These data suggest that minor elevations in glutamate concentration can be toxic to ganglion cells if this elevation is maintained for 3 months. Furthermore, memantine is efficacious at protecting ganglion cells from chronic low-dose glutamate toxicity.


This article has been cited by other articles:


Home page
 J. Neurosci.Home page
B. P. Buckingham, D. M. Inman, W. Lambert, E. Oglesby, D. J. Calkins, M. R. Steele, M. L. Vetter, N. Marsh-Armstrong, and P. J. Horner
Progressive Ganglion Cell Degeneration Precedes Neuronal Loss in a Mouse Model of Glaucoma
J. Neurosci., March 12, 2008; 28(11): 2735 - 2744.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
G. Chidlow, J. P. M. Wood, J. Manavis, N. N. Osborne, and R. J. Casson
Expression of Osteopontin in the Rat Retina: Effects of Excitotoxic and Ischemic Injuries
Invest. Ophthalmol. Vis. Sci., February 1, 2008; 49(2): 762 - 771.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
W. Fan, X. Li, and N. G. F. Cooper
CaMKII{alpha}B Mediates a Survival Response in Retinal Ganglion Cells Subjected to a Glutamate Stimulus
Invest. Ophthalmol. Vis. Sci., August 1, 2007; 48(8): 3854 - 3863.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
T. Filippopoulos, J. Danias, B. Chen, S. M. Podos, and T. W. Mittag
Topographic and Morphologic Analyses of Retinal Ganglion Cell Loss in Old DBA/2NNia Mice
Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1968 - 1974.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
Y. H. Yucel, N. Gupta, Q. Zhang, A. P. Mizisin, M. W. Kalichman, and R. N. Weinreb
Memantine protects neurons from shrinkage in the lateral geniculate nucleus in experimental glaucoma.
Arch Ophthalmol, February 1, 2006; 124(2): 217 - 225.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
S.-i. Manabe, Z. Gu, and S. A. Lipton
Activation of Matrix Metalloproteinase-9 via Neuronal Nitric Oxide Synthase Contributes to NMDA-Induced Retinal Ganglion Cell Death
Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4747 - 4753.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. A. Hancock, C. Guidry, R. W. Read, E. L. Ready, and T. W. Kraft
Acute Aminoglycoside Retinal Toxicity In Vivo and In Vitro
Invest. Ophthalmol. Vis. Sci., December 1, 2005; 46(12): 4804 - 4808.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
R. S. Mali, M. Cheng, and S. K. Chintala
Plasminogen activators promote excitotoxicity-induced retinal damage
FASEB J, August 1, 2005; 19(10): 1280 - 1289.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
W. A. Lagreze, A. Pielen, R. Steingart, G. Schlunck, H.-D. Hofmann, I. Gozes, and M. Kirsch
The Peptides ADNF-9 and NAP Increase Survival and Neurite Outgrowth of Rat Retinal Ganglion Cells In Vitro
Invest. Ophthalmol. Vis. Sci., March 1, 2005; 46(3): 933 - 938.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
S. Wamsley, B. T. Gabelt, D. B. Dahl, G. L. Case, R. W. Sherwood, C. A. May, M. R. Hernandez, and P. L. Kaufman
Vitreous Glutamate Concentration and Axon Loss in Monkeys With Experimental Glaucoma
Arch Ophthalmol, January 1, 2005; 123(1): 64 - 70.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
X. Luo, A. Baba, T. Matsuda, and C. Romano
Susceptibilities to and Mechanisms of Excitotoxic Cell Death of Adult Mouse Inner Retinal Neurons in Dissociated Culture
Invest. Ophthalmol. Vis. Sci., December 1, 2004; 45(12): 4576 - 4582.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
W. A. Hare, E. WoldeMussie, R. K. Lai, H. Ton, G. Ruiz, T. Chun, and L. Wheeler
Efficacy and Safety of Memantine Treatment for Reduction of Changes Associated with Experimental Glaucoma in Monkey, I: Functional Measures
Invest. Ophthalmol. Vis. Sci., August 1, 2004; 45(8): 2625 - 2639.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
P. Aoun, J. W. Simpkins, and N. Agarwal
Role of PPAR-{gamma} Ligands In Neuroprotection against Glutamate-Induced Cytotoxicity in Retinal Ganglion Cells
Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 2999 - 3004.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Danias, A. I. Kontiola, T. Filippopoulos, and T. Mittag
Method for the Noninvasive Measurement of Intraocular Pressure in Mice
Invest. Ophthalmol. Vis. Sci., March 1, 2003; 44(3): 1138 - 1141.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
Q. Li and D. G. Puro
Diabetes-Induced Dysfunction of the Glutamate Transporter in Retinal Muller Cells
Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 3109 - 3116.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
K. R. G. Martin, H. Levkovitch-Verbin, D. Valenta, L. Baumrind, M. E. Pease, and H. A. Quigley
Retinal Glutamate Transporter Changes in Experimental Glaucoma and after Optic Nerve Transection in The Rat
Invest. Ophthalmol. Vis. Sci., July 1, 2002; 43(7): 2236 - 2243.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
J. Danias, F. Shen, D. Goldblum, B. Chen, J. Ramos-Esteban, S. M. Podos, and T. Mittag
Cytoarchitecture of the Retinal Ganglion Cells in the Rat
Invest. Ophthalmol. Vis. Sci., March 1, 2002; 43(3): 587 - 594.
[Abstract] [Full Text] [PDF]

Home page
 IOVSHome page
H. Levkovitch–Verbin, H. A. Quigley, L. A. Kerrigan–Baumrind, S. A. D’Anna, D. Kerrigan, and M. E. Pease
Optic Nerve Transection in Monkeys May Result in Secondary Degeneration of Retinal Ganglion Cells
Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 975 - 982.
[Abstract] [Full Text]

Home page
 IOVSHome page
X. Luo, V. Heidinger, S. Picaud, G. Lambrou, H. Dreyfus, J. Sahel, and D. Hicks
Selective Excitotoxic Degeneration of Adult Pig Retinal Ganglion Cells In Vitro
Invest. Ophthalmol. Vis. Sci., April 1, 2001; 42(5): 1096 - 1106.
[Abstract] [Full Text]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. E. Donello, E. U. Padillo, M. L. Webster, L. A. Wheeler, and D. W. Gil
{alpha}2-Adrenoceptor Agonists Inhibit Vitreal Glutamate and Aspartate Accumulation and Preserve Retinal Function after Transient Ischemia
J. Pharmacol. Exp. Ther., January 1, 2001; 296(1): 216 - 223.
[Abstract] [Full Text]

Home page
 IOVSHome page
F. Schuettauf, R. Naskar, C. K. Vorwerk, D. Zurakowski, and E. B. Dreyer
Ganglion Cell Loss after Optic Nerve Crush Mediated through AMPA-Kainate and NMDA Receptors
Invest. Ophthalmol. Vis. Sci., December 1, 2000; 41(13): 4313 - 4316.
[Abstract] [Full Text]

Home page
 IOVSHome page
J. Ambati, C. S. Canakis, J. W. Miller, E. S. Gragoudas, A. Edwards, D. J. Weissgold, I. Kim, F. C. Delori, and A. P. Adamis
Diffusion of High Molecular Weight Compounds through Sclera
Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 1181 - 1185.
[Abstract] [Full Text]

Home page
 IOVSHome page
J. Ambati, E. S. Gragoudas, J. W. Miller, T. T. You, K. Miyamoto, F. C. Delori, and A. P. Adamis
Transscleral Delivery of Bioactive Protein to the Choroid and Retina
Invest. Ophthalmol. Vis. Sci., April 1, 2000; 41(5): 1186 - 1191.
[Abstract] [Full Text]

Home page
 Arch OphthalmolHome page
T. W. Kim, K. B. Kang, H.-K. Choung, K. H. Park, and D. M. Kim
Elevated Glutamate Levels in the Vitreous Body of an In Vivo Model of Optic Nerve Ischemia
Arch Ophthalmol, April 1, 2000; 118(4): 533 - 536.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
T. M. Nork, J. N. Ver Hoeve, G. L. Poulsen, R. W. Nickells, M. D. Davis, A. J. Weber, Vaegan, S. H. Sarks, H. L. Lemley, and L. L. Millecchia
Swelling and Loss of Photoreceptors in Chronic Human and Experimental Glaucomas
Arch Ophthalmol, February 1, 2000; 118(2): 235 - 245.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
J. Morgan, J. Caprioli, and Y. Koseki
Nitric Oxide Mediates Excitotoxic and Anoxic Damage in Rat Retinal Ganglion Cells Cocultured With Astroglia
Arch Ophthalmol, November 1, 1999; 117(11): 1524 - 1529.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
R. N. Weinreb and L. A. Levin
Is Neuroprotection a Viable Therapy for Glaucoma?
Arch Ophthalmol, November 1, 1999; 117(11): 1540 - 1544.
[Abstract] [Full Text] [PDF]

Home page
 J. Neurosci.Home page
N. Klocker, P. Kermer, M. Gleichmann, M. Weller, and M. Bahr
Both the Neuronal and Inducible Isoforms Contribute to Upregulation of Retinal Nitric Oxide Synthase Activity by Brain-Derived Neurotrophic Factor
J. Neurosci., October 1, 1999; 19(19): 8517 - 8527.
[Abstract] [Full Text] [PDF]

Home page
 JAMAHome page
E. B. Dreyer and S. A. Lipton
New Perspectives on Glaucoma
JAMA, January 27, 1999; 281(4): 306 - 308.
[Full Text] [PDF]

Home page
 J. Neurophysiol.Home page
E. D. Cohen
Interactions of Inhibition and Excitation in the Light-Evoked Currents of X Type Retinal Ganglion Cells
J Neurophysiol, December 1, 1998; 80(6): 2975 - 2990.
[Abstract] [Full Text] [PDF]

Home page
 Arch OphthalmolHome page
E. Yoles and M. Schwartz
Elevation of Intraocular Glutamate Levels in Rats With Partial Lesion of the Optic Nerve
Arch Ophthalmol, July 1, 1998; 116(7): 906 - 910.
[Abstract] [Full Text] [PDF]

Home page
 NeuroscientistHome page
M. E.M. Kelly and S. Barnes
Physiology and Pathophysiology of Nitric Oxide in the Retina
Neuroscientist, November 1, 1997; 3(6): 357 - 360.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the Association for Research in Vision and Ophthalmology